Skip to main content

GoodRx Holdings, Inc.

For the period ended Mar 31, 2025. Filed May 7, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2025 · Filed May 7, 2025

GDRX$3.54-3.0%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Statements of Operations

Three Months Ended March 31,
(in thousands, except for per share amounts)20252024
Revenue$202,970$197,880
Costs and operating expenses:
Cost of revenue, exclusive of depreciation and amortization presented separately below13,36412,468
Product development and technology31,14231,017
Sales and marketing84,54289,964
General and administrative29,63041,108
Depreciation and amortization20,91215,942
Total costs and operating expenses179,590190,499
Operating income23,3807,381
Other expense, net:
Interest income3,9327,555
Interest expense(10,644)(14,643)
Total other expense, net(6,712)(7,088)
Income before income taxes16,668293
Income tax expense(5,616)(1,302)
Net income (loss)$11,052$(1,009)
Earnings (loss) per share:
Basic$0.03$(0.00)
Diluted$0.03$(0.00)
Weighted average shares used in computing earnings (loss) per share:
Basic379,196390,048
Diluted379,656390,048
Stock-based compensation included in costs and operating expenses:
Cost of revenue$100$76
Product development and technology5,6705,848
Sales and marketing5,8828,127
General and administrative7,52211,045
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.